# FOSFOMYCIN TROMETHAMINE
> **ANDA211881** · Abbreviated New Drug Application (Generic) · Sponsor: CIPLA · Approved 2022-01-26
## Drug
- **FDA Application Number:** ANDA211881
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** FOSFOMYCIN TROMETHAMINE
- **Generic name:** FOSFOMYCIN TROMETHAMINE
- **Active ingredients:** FOSFOMYCIN TROMETHAMINE
- **Dosage form:** FOR SOLUTION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** CIPLA
- **Manufacturer:** Cipla USA Inc.
- **First approval:** 2022-01-26
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211881)
---
*MORVS · CC0 1.0*